BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8429620)

  • 1. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adulterants causing false negatives in illicit drug testing.
    Mikkelsen SL; Ash KO
    Clin Chem; 1988 Nov; 34(11):2333-6. PubMed ID: 3052928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ; Pelders MG; Egberts AC
    J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
    Goldberger BA; Cone EJ
    J Chromatogr A; 1994 Jul; 674(1-2):73-86. PubMed ID: 8075776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First analytical chemistry study on drug abuse in the Buenos Aires (Argentina) University students.
    Quiroga PN; Panzuto RI; Alvarez GB; Mirson DJ; Ochoa CF; Assem EM; López CM; Schkolnik LC; Villaamil EC; Roses OE
    Farmaco; 1998 Jun; 53(6):389-94. PubMed ID: 9764470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.
    Kerrigan S; Phillips WH
    Clin Chem; 2001 Mar; 47(3):540-7. PubMed ID: 11238309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine.
    Pérez-Bendito D; Gómez-Hens A; Gaikwad A
    Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
    Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
    J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of herbal drinks with urinalysis for drugs of abuse.
    Winek CL; Elzein EO; Wahba WW; Feldman JA
    J Anal Toxicol; 1993; 17(4):246-7. PubMed ID: 8371557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adulterants on RIA analysis of urine for drugs of abuse.
    Cody JT; Schwarzhoff RH
    J Anal Toxicol; 1989; 13(5):277-84. PubMed ID: 2615338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.